
|Articles|November 15, 2002
Brimonidine may replace beta-blockers for older patients
Tucson, AZ-Topical beta-blockers have been a mainstay of ongoing treatment for glaucoma for more than 20 years, but a new study adds to the evidence that they may not be the best option for long-term control of IOP for elderly patients.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
2
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
3
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
4
Port Delivery System Therapies in Retinal Vascular Diseases
5






















